Microbiology

  1. SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease

    1. Pengfei Wang
    2. Lihong Liu
    3. Manoj S. Nair
    4. Michael T. Yin
    5. Yang Luo
    6. Qian Wang
    7. Ting Yuan
    8. Kanako Mori
    9. Axel Guzman Solis
    10. Masahiro Yamashita
    11. Lawrence J. Purpura
    12. Justin C. Laracy
    13. Jian Yu
    14. Joseph Sodroski
    15. Yaoxing Huang
    16. David D. Ho

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV

    1. Ye Qiu
    2. Qiong Wang
    3. Jin-Yan Li
    4. Ce-Heng Liao
    5. Zhi-Jian Zhou
    6. Xing-Yi Ge

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

    1. Daming Zhou
    2. Helen ME Duyvesteyn
    3. Cheng-Pin Chen
    4. Chung-Guei Huang
    5. Ting-Hua Chen
    6. Shin-Ru Shih
    7. Yi-Chun Lin
    8. Chien-Yu Cheng
    9. Shu-Hsing Cheng
    10. Yhu-Chering Huang
    11. Tzou-Yien Lin
    12. Che Ma
    13. Jiandong Huo
    14. Loic Carrique
    15. Tomas Malinauskas
    16. Reinis R Ruza
    17. Pranav NM Shah
    18. Tiong Kit Tan
    19. Pramila Rijal
    20. Robert F. Donat
    21. Kerry Godwin
    22. Karen Buttigieg
    23. Julia Tree
    24. Julika Radecke
    25. Neil G Paterson
    26. Piyasa Supasa
    27. Juthathip Mongkolsapaya
    28. Gavin R Screaton
    29. Miles W. Carroll
    30. Javier G. Jaramillo
    31. Michael Knight
    32. William James
    33. Raymond J Owens
    34. James H. Naismith
    35. Alain Townsend
    36. Elizabeth E Fry
    37. Yuguang Zhao
    38. Jingshan Ren
    39. David I Stuart
    40. Kuan-Ying A. Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Validation and performance of a quantitative IgG assay for the screening of SARS-CoV-2 antibodies

    1. Ana M. Espino
    2. Petraleigh Pantoja
    3. Carlos A. Sariol

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

    1. Jana Krüger
    2. Rüdiger Groß
    3. Carina Conzelmann
    4. Janis A. Müller
    5. Lennart Koepke
    6. Konstantin M. J. Sparrer
    7. Desiree Schütz
    8. Thomas Seufferlein
    9. Thomas F.E. Barth
    10. Steffen Stenger
    11. Sandra Heller
    12. Alexander Kleger
    13. Jan Münch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice

    1. Linlin Bao
    2. Wei Deng
    3. Baoying Huang
    4. Hong Gao
    5. Jiangning Liu
    6. Lili Ren
    7. Qiang Wei
    8. Pin Yu
    9. Yanfeng Xu
    10. Feifei Qi
    11. Yajin Qu
    12. Fengdi Li
    13. Qi Lv
    14. Wenling Wang
    15. Jing Xue
    16. Shuran Gong
    17. Mingya Liu
    18. Guanpeng Wang
    19. Shunyi Wang
    20. Zhiqi Song
    21. Linna Zhao
    22. Peipei Liu
    23. Li Zhao
    24. Fei Ye
    25. Huijuan Wang
    26. Weimin Zhou
    27. Na Zhu
    28. Wei Zhen
    29. Haisheng Yu
    30. Xiaojuan Zhang
    31. Li Guo
    32. Lan Chen
    33. Conghui Wang
    34. Ying Wang
    35. Xinming Wang
    36. Yan Xiao
    37. Qiangming Sun
    38. Hongqi Liu
    39. Fanli Zhu
    40. Chunxia Ma
    41. Lingmei Yan
    42. Mengli Yang
    43. Jun Han
    44. Wenbo Xu
    45. Wenjie Tan
    46. Xiaozhong Peng
    47. Qi Jin
    48. Guizhen Wu
    49. Chuan Qin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters

    1. Nikolaus Osterrieder
    2. Luca D. Bertzbach
    3. Kristina Dietert
    4. Azza Abdelgawad
    5. Daria Vladimirova
    6. Dusan Kunec
    7. Donata Hoffmann
    8. Martin Beer
    9. Achim D. Gruber
    10. Jakob Trimpert

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy

    1. Lucio Ayres Caldas
    2. Fabiana Avila Carneiro
    3. Luiza Mendonça Higa
    4. Fábio Luiz Monteiro
    5. Gustavo Peixoto da Silva
    6. Luciana Jesus da Costa
    7. Edison Luiz Durigon
    8. Amilcar Tanuri
    9. Wanderley de Souza

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Designed peptides as potential fusion inhibitors against SARA-CoV-2 coronavirus infection

    1. Ke Chen
    2. Shihao Bai
    3. Xin Zou
    4. Jie Hao
    5. Lin-tai Da
    6. Ze-Guang Han

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

    1. Fabian Schmidt
    2. Yiska Weisblum
    3. Frauke Muecksch
    4. Hans-Heinrich Hoffmann
    5. Eleftherios Michailidis
    6. Julio C. C. Lorenzi
    7. Pilar Mendoza
    8. Magdalena Rutkowska
    9. Eva Bednarski
    10. Christian Gaebler
    11. Marianna Agudelo
    12. Alice Cho
    13. Zijun Wang
    14. Anna Gazumyan
    15. Melissa Cipolla
    16. Marina Caskey
    17. Davide F. Robbiani
    18. Michel C. Nussenzweig
    19. Charles M. Rice
    20. Theodora Hatziioannou
    21. Paul D. Bieniasz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 57 of 251 Next